Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-22T22:37:26.987Z Has data issue: false hasContentIssue false

Moving toward Elimination of Healthcare-Associated Infections: A Call to Action

Published online by Cambridge University Press:  02 January 2015

Denise Cardo
Affiliation:
Centers for Disease Control and Prevention (CDC), Division of Healthcare Quality Promotion (DHQP)
Penelope H. Dennehy
Affiliation:
Pediatric Infectious Diseases Society (PIDS)
Paul Halverson
Affiliation:
Association of State and Territorial Health Officials (ASTHO)
Neil Fishman
Affiliation:
Society of Healthcare Epidemiology of America (SHEA)
Mel Kohn
Affiliation:
Council of State and Territorial Epidemiologists (CSTE)
Cathryn L. Murphy
Affiliation:
Association for Professionals in Infection Control and Epidemiology (APIC)
Richard J. Whitley
Affiliation:
Infectious Diseases Society of America (IDSA)

Extract

Jointly, the Association for Professionals in Infection Control and Epidemiology (APIC), the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), the Association of State and Territorial Health Officials (ASTHO), the Council of State and Territorial Epidemiologists (CSTE), Pediatric Infectious Diseases Society (PIDS), and the Centers for Disease Control and Prevention (CDC) propose a call to action to move toward the elimination of healthcare-associated infections (HAIs) by adapting the concept and plans used for the elimination of other diseases, including infections. Elimination, as defined for other infectious diseases, is the maximal reduction of “the incidence of infection caused by a specific agent in a defined geographical area as a result of deliberate efforts; continued measures to prevent reestablishment of transmission are required.” (p24) This definition has been useful for elimination efforts directed toward polio, tuberculosis, and syphilis and can be readily adapted to HAIs. Sustained elimination of HAIs can be based on this public health model of constant action and vigilance. Elimination will require the implementation of evidence-based practices, the alignment of financial incentives, the closing of knowledge gaps, and the acquisition of information to assess progress and to enable response to emerging threats. These efforts must be under-pinned by substantial research investments, the development of novel prevention tools, improved organizational and personal accountabilities, strong collaboration among a broad coalition of public and private stakeholders, and a clear national will to succeed in this arena.

Type
White Paper
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention (CDC). Global disease elimination and eradication as public health strategies. Proceedings of a conference. Atlanta, Georgia, USA. 23-25 February 1998. MMWR Morb Mortal Wkly Rep 1999;48(suppl):1-208. http://www.cdc.gov/mmwr/pdf/other/mm48su01.pdf. Accessed 26 August 2010.Google Scholar
2.Dowdle, WR. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1989;38(suppl S-3):125.Google Scholar
3.Centers for Disease Control and Prevention. The national plan to eliminate syphilis from the United States. Atlanta, GA: US Department of Health and Human Services; 2006.Google Scholar
4.Notes from the decennial [commentary]. Am J Infect Control 2010;38(5):337340.Google Scholar
5.Klevens, R, Edwards, JR, Richards, CL, et al.Estimating healthcare-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007;122:160166.CrossRefGoogle ScholarPubMed
6.World Health Organization. WHO guidelines on hand hygiene in health care. The first global patient safety challenge: clean care is safer care. Geneva: World Health Organization; 2009.Google Scholar
7.Hidron, AI, Edwards, JR, Patel, J, et al.NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:9961011.CrossRefGoogle Scholar
8.Perman, JW. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci-from disaster to ongoing control. J Hosp Infect 2006;63(1):1426.CrossRefGoogle Scholar
9.Pearson, A, Chronias, A, Murray, M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and meth-icillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009;64(suppl 1):i11i17.CrossRefGoogle ScholarPubMed
10.Carlet, J, Astagneau, P, Brun-Buisson, C, et al.French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009;30:737745.CrossRefGoogle ScholarPubMed
11.Burton, DC, Edwards, JR, Horan, TC, Jernigan, JA, Fridkin, SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009;301(7):727736.Google Scholar
12.Centers for Disease Control and Prevention. Healthcare Infection Control Practices Advisory Committee (HICPAC). http://www.cdc.gov/hicpac/index.html. Accessed 10 August 2010.Google Scholar
13. American Recovery and Reinvestment Act of 2009, Pub L No. 111-115, 111 Stat 1 (2009).Google Scholar
14.McKibben, L, Horan, T, Tokars, JI, et al.Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control 2005;33:217226.Google Scholar
15. Deficit Reduction Act, Pub L No. 109-171, 109 Stat 1932 (2006).Google Scholar
16. Patient Protection and Affordable Care Act, Pub L No. 111-148, 111 Stat 3590 (2010).Google Scholar
17. Hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates, 75 Federal Register 157 (2010) (codified at 42 CFR §411-§422 and §489).Google Scholar
18.Pronovost, P, Needham, D, Berenholtz, S, et al.An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl ] Med 2006;355:27252732.CrossRefGoogle ScholarPubMed
19.Centers for Disease Control and Prevention (CDC). Reduction in central line-associated bloodstream infections among patients in intensive care units–Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005;54:10131016.Google Scholar
20.Pronovost, P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control 2008;36:S171.elS171.e5.Google Scholar
21. 5 Million Lives Campaign. Getting started kit: prevent central line infections how-to guide. Cambridge, MA: Institute for Healthcare Improvement; 2008. http://www.ihi.org. Accessed 6 July 2010.Google Scholar
22.Institute for Healthcare Improvement. Plan-Do-Study-Act (PDSA) Worksheet (IHI Tool). http://www.ihi.org/IHI/Topics/Improvement/ImprovementMethods/Tools/. Accessed 6 July 2010.Google Scholar
23.Yokoe, DS, Mermel, LA, Anderson, DJ, et al.A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S12S21.CrossRefGoogle ScholarPubMed
24.Association for Professionals in Infection Control and Epidemiology. APIC elimination guides, http://www.apic.org/AM/Template.cnrtfSection=APIC_Elimination_Guides&Template=/CM/HTMLDisplay.cfm&ContentID=14743. Accessed 10 February 2010.Google Scholar
25.Pronovost, P. Overview of STOP-BSI program. Oral presentation to Healthcare Infection Control Practices Advisory Committee (HICPAC); November 2009; Washington, DC.Google Scholar
26.Khoury, MJ, Gwinn, M, Yoon, PW, Dowling, N, Moore, CA, Bradley, L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665674.Google Scholar
27.The Research Committee of the Society of Healthcare Epidemiology of America. Enhancing patient safety by reducing healthcare-associated infections: the role of discovery and dissemination. Infect Control Hosp Epidemiol 2010;31:118123.CrossRefGoogle Scholar